본문으로 바로가기

행사/교육

의약바이오 국제심포지움 개최 안내

  • 등록일2012-04-13
  • 조회수3850
  • 구분 국내
  • 행사교육분류 행사
  • 주관기관
    오송첨단의료산업진흥재단(임상시험신약생산센터)
  • 행사장소
    Hotel Riviera (Daejeon Korea)
  • 행사기간
    2012-04-19
  • 원문링크
  • 첨부파일

의약바이오 국제심포지움 개최 안내

 

 

1. 주제 : Outsourcing Strategy of Biopharmaceutical Development & Production

 

2. 일시 : 2012년 4월 19일, 09:30 ~ 17:30

 

3. 장소 : 리베라호텔 (대전광역시 유성구)

 

4. 참가비: 무료 (장소와 식사준비 관계로 미리 등록신청을 해주시기를 부탁드립니다)

 

5. 주최 : 오송첨단의료산업진흥재단

 

6. 문의 및 등록신청 : 임상시험신약생산센터 정경희 (043-273-1460, tim@kbio.kr)

 

      ※ 신청시 아래 양식으로 메일을 부탁합니다.

 

기 관

 

부 서

 

성 명

 

연락처

전화:

이메일


※ 초청연사와의 개별 미팅 (18일 저녁~ 19일 저녁)을 원하시는 분은 사전 문의 바랍니다

 

 

PROGRAM

 

09:30-10:00   Registration
10:00-10:15   Opening
10:15-10:45   Regulation & Guideline for Biopharmaceutical Manufacturing (KFDA)
10:45-12:00   Dealing with a CMO : Considerations, Premises and Opportunities

                     (InnoBiologics)
12:00-13:00   Lunch
13:00-14:00   Challenges in Biopharmaceutical Process Development and Clinical

                     Manufacturing (DCB)
14:00-15:00   New Trends of Protein Purification Technology for CMO (Satorius AG)
15:00-15:30   Coffee Break & Networking
15:30-16:15   BINEX and CMO Experiences (KBCC/BINEX)
16:15-17:00   Advances and Trends in Biopharmaceutical Manufacturing Design (SNC

                     Lavalin)
17:00-17:30   Closing Remark

 

 

Invited Speakers

 

Dr. Joachim K Walter (Senior VP Biopharmaceutical Operations, InnoBiologics)
- Senior level scientific & management executive with 26+years of experience in the development and manufacture of biopharmaceutical proteins derived from mammalian cell culture.
- Unit VP Head of Membrane Separation Sciences GE Healthcare (2002 - 2006)
- Head of Research and Development Protein Chemistry Boehringer Ingelheim Pharma KG (1985 ~2002)

 

Dr. Wei-Kuang Chi (Vice President, Development Center for Biotechnology)
- He has been responsible for the establishment of DCB’s multi-product CGMP Biopharmaceutical Pilot Plant
- This facility has been certified by Taiwan Department of Health and received DMF with USA FDA and has joined Boehringer Ingelheim Biopharmaceuticals Production Alliance Network since 2007.
- This CGMP facility has received six IND approvals from US FDA, Canadian health authority, EMA.

 

Dr. Uwe Gottschalk (Vice President, Purification Technologies Sartorius AG)
- Bayer Health Care from 1991-2004
- Head of the GMP protein purification facility in Wuppertal (Germany) responsible for the production of monoclonal antibodies and other recombinant proteins using various expression systems
- Member of BioPharm International’s editorial advisory board
- Board member of the VBU Association of Germany Biotech Companies

 

Jeong-Won Suh (Director in Production in Binex)
- Over 25 years of experience in biopharma production, GMP, facility design and scale-up (LG)
- Building of several CGMP facility, passing the inspection of KFDA, USA FDA, EMA, WHO.

 

Todd P. Farrel (Project Manager, SNC Lavalin)
- Over 15 years of experience in process engineering, design and project management.
- Mr. Farrell has vast experience in pharmaceutical and biotechnology equipment/ facility design
- He has managed several projects for large international biopharmaceutical companies.